socalTECH

FEBRUARY 9, 2021

San Diego-based virtual reality startup Nanome, which is developing technology to help researchers explore the interaction of molecules and molecular compounds using VR, has raised $3M in a funding round, the company disclosed today.

San Diego 113

San Diego Venture Capital Research Tool 113

socalTECH

SEPTEMBER 16, 2014

Startups related to the many University of California campuses in Southern California may soon have a new source of funding: The University of California itself, via a new, $250M venture capital. The fund would seek to invest in companies started on campus, from University research, and from students. READ MORE>>.

Venture Capital 223

Venture Capital Capital UCLA UCSD 223

socalTECH

DECEMBER 16, 2022

San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the public of $17.25 per share, and is now expecting to raise $207M for the company. The company is working on RNA therapeutics.

San Diego 113

San Diego Research Pricing Platform 113

socalTECH

APRIL 29, 2021

San Diego- and Shanghai-based Adcentryx Therapeutics, a biotechnology company focused on antibody drug conjugate (ADC) therapeutic development, says it has raised $50M in its Series A funding round. The funding was led by CBC Group, and also included Zoo Capital the venture arm of Boyu Capital.

Funding 113

Funding San Diego Research Capital 113

socalTECH

MAY 26, 2021

San Diego-based Phanes Therapeutics, a developer of immuno-oncology drugs, has raised $40M in its Series B funding round. The funding was led by Sequoia Capital China, and also included the company other investors. Names of the other investors were not announced by the company. Ming Wang, PhD/MBA is CEO of Phanes Therapeutics.

San Diego 113

San Diego Research Funding Capital 113

socalTECH

JANUARY 29, 2021

San Diego-based Encodia, a biotech company which is focused on proteomics research, has raised $75M in a Series C funding round, the company said this week.

San Diego 113

San Diego Research Capital Funding 113

socalTECH

APRIL 28, 2021

San Diego-based Boundless Bio, a company developing therapeutics for treating cancer, has raised $105M in its Series B funding, the company said this morning. The company said it will use the funding to support development of its multiple programs. Boundless Bio is led by Zachary Hornby, President and Chief Executive Officer.

San Diego 113

San Diego Research Capital Invest 113

socalTECH

JULY 20, 2021

San Diego-based Wugen, a biotechnology company which is developing treatments for solid tumors, recently annoucned a $172M, Series B funding round. Managing Partner at Abingworth, Bosun Hau, Managing Director at Tybourne Capital Management, and Peter Kiener, Ph.D., Bali Muralidhar, M.D., Bali Muralidhar, M.D.,

San Diego 113

San Diego Capital Research Platform 113

socalTECH

NOVEMBER 10, 2020

San Diego-based biopharmaceuticals developer Ambrx has raised $200M in a funding round, according to the company, which included Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, Cormorant Asset Management, HBM Healthcare Investments, Invus, Adage Capital Partners and Suvretta Capital Management.

San Diego 113

San Diego Research Capital Invest 113

socalTECH

SEPTEMBER 8, 2021

San Diego-based Replicate Bioscience, which is looking to use self-replicating RNA (srRNA) to treat cancer, autoimmune, inflammatory disorders and other diseases, has raised $40M in its Series A funding. The funding was led by life sciences venture capital investor ATP. and Zachary Hartman, Ph.D.,

San Diego 113

San Diego Venture Capital Research Funding 113

Xconomy

SEPTEMBER 10, 2019

Fall is finally arriving, as indicated by the recent shortened work week, and few may object given the unseasonably hot, muggy weather San Diego has been experiencing recently. Oxford Finance and BroadOak Capital Partners also participated.

San Diego 46

San Diego Capital Develop Development 46

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JANUARY 10, 2020

San Diego-based Element Biosciences , which is developing DNA sequencing technology, says it has raised $80M in a Series B funding round. The new funding came from Fidelity Management & Research Company and JS Capital LLC, along with Foresite Capital and Venrock. Molly He, PhD is CEO and co-founder of Element.

San Diego 100

San Diego Research Capital Funding 100

socalTECH

JULY 28, 2021

San Diego-based immunology startup Aristea Therapeutics says it has raised $63M in a Series B financing round, which was led by Fidelity Management & Research Company, LLC, along with Novo Holdings A/S, plus Arena Pharmaceuticals and funds managed by Tekla Capital Management, LLC.

San Diego 100

San Diego Study Research Capital 100

socalTECH

SEPTEMBER 19, 2008

Venture capital firm Sofinnova Ventures has hired on an Executive-in-Residence based in San Diego, the firm said Thursday. Ekman is te former EVP and President of Global Research and Development at Elan Corporation. Sofinnova, which invests in early stage life sciences and IT firms, said it has appointed Lars Ekman, M.D.,

San Diego 100

San Diego Venture Capital Research Capital 100

socalTECH

JULY 13, 2020

San Diego-based biopharmaceuticals firm Poseida Therapeutics successfully made it to the public markets with an IPO on Friday, raising $224M in an offering on the Nasdaq Global Select Market. Poseida is backed by Fidelity Management Research Company, LLC, Adage Capital Management and Schonfeld Strategic Advisors, READ MORE>>.

San Diego 113

San Diego Research Pricing Capital 113

socalTECH

AUGUST 5, 2021

San Diego-based Aardvark Therapeutics, a biopharmaceuticals company focused on metabolic diseases, said this morning that it has raised $29M in its Series B funding round. The company said the funding will go towards three Phase 2 clinical trails of its lead compound, and to advance several potential additional formulations.

San Diego 140

San Diego Research Funding Invest 140

socalTECH

JANUARY 25, 2012

San Diego-based StockTwits , the finance and stock-focused micro-messaging service headed by Howard Lindzon, reported that S&P Capital IQ , a provider of market research and financial information, is using its StockTwits Pro service.

Capital 133

Capital San Diego Equity Research 133

socalTECH

DECEMBER 30, 2016

Here, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund, and has had some great success in the market. TVC Capital has also been a big supporter and sponsor of socaltech over the years. You can see all of our holiday reflections here. Risk taking yields innovation.

Capital 113

Capital Southern California Equity San Diego 113

socalTECH

JUNE 5, 2017

San Diego-based Comhear , a developer of immersive, 3D audio software, announced on Monday that it has raised $12M in a Series A funding. The company said its technology is based on research from the University of California San Diego (UCSD). Comhear develops audio enhancing software. READ MORE>>.

UCSD 147

UCSD San Diego Equity Research 147

socalTECH

NOVEMBER 3, 2021

San Diego-based Model Medicines, a company that is developing artificial intelligence and machine learning software for the drug discovery and development process, has raised $4.1M in a funding round. The funding came from 8VC, Irving Investors, Particle X and Nex Cubed.

Artificial Inteligence 133

Artificial Inteligence San Diego Research Platform 133

socalTECH

OCTOBER 29, 2019

San Diego-based Boundless Bio , the biopharmaceuticals startup which recently raised $46M for treating aggressive cancers , has named Christian ("Chris") Hassig, Ph.D., as its Chief Scientific Officer. READ MORE>>.

San Diego 100

San Diego Research Capital Invest 100

Xconomy

MARCH 13, 2018

At Intel Capital in the Bay Area, investment director Ranjeet Alexis is an expert in bioinformatics who is scouting for deals at the intersection of computation, healthcare, and the life sciences. His investments include Synthego , a provider of technology used in CRISPR genome editing and research.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

socalTECH

MAY 9, 2019

Are you willing to share your DNA with researchers, if only they'd pay you something for that data? San Diego-based LunaPBC , which operates the online LunaDNA genomic and health data community, has raised $4.6M in a funding round, according to the company.

Platform 100

Platform Research San Diego Funding 100

socalTECH

JUNE 25, 2020

San Diego-based biopharmaceuticals developer Poseida Therapeutics has raised $110M more in funding, in its Series D round, the company announced this morning.

San Diego 113

San Diego Research Platform Sites 113

socalTECH

JULY 16, 2019

San Diego-based Trefoil Therapeutics , which is developing treatments for corneal diseases, has raised $28M in its Series A funding, the company said on Tuesday. joins the company's board; Robertson was formerly vice president in Research & Development at Alcon Laboratories. Robertson, Ph.D.,

San Diego 113

San Diego Research Funding Capital 113

socalTECH

OCTOBER 22, 2018

San Diego-based Qpex Biopharma announced this morning that it has raised $33M in a Series A funding round, to launch its efforts to battle drug-resistant infections. The company also said it has an agreement with the Biomedical Advanced Research and Development Authority (BARDA), worth up to a total award of $132M.

Develop 133

Develop Development Draper San Diego 133

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The technology behind the Avelas product is based on research conducted at UC San Diego. in a Series B funding. READ MORE>>.

Avalon 147

Avalon San Diego Venture Capital Research 147

Xconomy

OCTOBER 8, 2019

Scientists, no matter how sexy the research they’re conducting, aren’t immune from the administrative minutiae of office life. Such tasks steal time away from researchers’ main objectives. However, that wasn’t the problem San Diego startup LabFellows was looking to solve when it launched in 2014.

San Diego 112

San Diego Research Startup Help 112

socalTECH

FEBRUARY 24, 2020

San Diego-based Arima Genomics , a startup working on research tools for understanding genome sequence and structure, said this morning that it has raised a Series A funding round. Size of the funding was not announced.

Funding 113

Funding San Diego Research Tool 113

socalTECH

NOVEMBER 14, 2017

San Diego-based cancer immunotherapy developer OncoSec Medical says it has raised $9.3M The company said the funds received in the warrant exercise will go towards working capital and general corporate purposes, a clinical trial, and other research and development. via a warrant exercise agreement. READ MORE>>.

San Diego 113

San Diego Research Capital Funding 113

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

JANUARY 21, 2021

San Diego- and New Jersey-based OncoSec Medical, a publicly traded biotechnology company focused on treatment of cancer, said today that it is raising $42.0M in a public offering of its common stock. The company said it is offering of 7,711,284 shares of its common stock at a price of $5.45, with an expected close on January 25th.

San Diego 113

San Diego Activity Research Pricing 113

socalTECH

JANUARY 7, 2013

A new, biotech startup focused on delivery of nucleic acid therapeutics, Solstice Biologics , said last week that it has licensed technology developed at UC San Diego, and received $18M in a Series A funding. and his colleagues at UC San Diego School of Medicine. READ MORE>>.

UCSD 164

UCSD San Diego Technology Startup 164

socalTECH

DECEMBER 22, 2020

San Diego-based Neomorph , a biotech startup focused on protein degradation, said today that it has raised $109M in a Series A funding. The company said it will use the Series A funding to further develop its platform, advance lead programs, and expand the research team. The funding came from Deerfield Management.

San Diego 113

San Diego Research Platform Funding 113

socalTECH

MAY 8, 2018

San Diego-based LunaDNA , which is developing a "community owned" platform for genomic and medical research information, said on Tuesday that it has raised $4M in a funding round.

San Diego 100

San Diego Platform Research Funding 100

socalTECH

SEPTEMBER 27, 2016

San Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. READ MORE>>.

Avalon 100

Avalon San Diego Research Capital 100